feed,title,long_url,short_url
Benzinga,Cellectar Biosciences Is An 'Attractive Acquisition Target' According To This Analyst - Here's Why,https://benzinga.com/analyst-ratings/analyst-color/24/03/37465044/cellectar-biosciences-is-an-attractive-acquisition-target-according-to-this-analyst,https://da.gd/i5LxcH
Benzinga,Behind the Scenes of Toll Brothers's Latest Options Trends,https://benzinga.com/insights/options/24/03/37465028/behind-the-scenes-of-toll-brotherss-latest-options-trends,https://da.gd/dnakEP
Benzinga,Smart Money Is Betting Big In CCL Options,https://benzinga.com/insights/options/24/03/37465022/smart-money-is-betting-big-in-ccl-options,https://da.gd/ElW9c
Benzinga,What the Options Market Tells Us About General Electric,https://benzinga.com/insights/options/24/03/37465021/what-the-options-market-tells-us-about-general-electric,https://da.gd/ABnsf
